Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › FDA Approves Three Tests for Determining Appropriate Use of Skin Infection Drug

FDA Approves Three Tests for Determining Appropriate Use of Skin Infection Drug

Oct 31, 2017
|
staff reporter

NEW YORK (360Dx) – Melinta Therapeutics said this week that the US Food and Drug Administration has cleared three antimicrobial susceptibility tests to help guide physicians in the use of Melinta's drug to treatment for bacterial skin and skin structure infections.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  2. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  3. Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

  4. FDA Grants Emergency Use Authorization for Jiangsu Well Biotech Coronavirus Antibody Test

  5. Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.